These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39025210)

  • 1. A Xenograft Model of Kaposiform Hemangioendothelioma in Nude Mice Recapitulates Kasabach-Merritt Phenomenon.
    Wang Q; Qiu WW; Li MY; Shen WM; Yuan SM
    Ann Vasc Surg; 2024 Nov; 108():419-425. PubMed ID: 39025210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of Kaposiform hemangioendothelioma.
    Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
    Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
    Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
    Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
    Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: ultrastructural observation and immunohistochemistry staining reveal the trapping of blood components.
    Yuan SM; Hong ZJ; Chen HN; Shen WM; Zhou XJ
    Ultrastruct Pathol; 2013 Dec; 37(6):452-5. PubMed ID: 24134598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
    Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
    Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
    Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
    Croteau SE; Liang MG; Kozakewich HP; Alomari AI; Fishman SJ; Mulliken JB; Trenor CC
    J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report.
    Liu L; Gu W; Teng L; Xu Y; Zheng F; Hu M; Lu M; Xu X
    BMC Pediatr; 2023 Nov; 23(1):574. PubMed ID: 37978357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
    Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
    Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposiform hemangioendothelioma: current knowledge and future perspectives.
    Ji Y; Chen S; Yang K; Xia C; Li L
    Orphanet J Rare Dis; 2020 Feb; 15(1):39. PubMed ID: 32014025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
    Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
    Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypically presenting kaposiform hemangioendothelioma of the knee: ultrasound findings.
    Erdem Toslak I; Stegman M; Reiter MP; Barkan GA; Borys D; Lim-Dunham JE
    J Med Ultrason (2001); 2018 Oct; 45(4):653-656. PubMed ID: 29637402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
    Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
    Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
    Ji Y; Chen S; Zhou J; Yang K; Zhang X; Xiang B; Qiu T; Gong X; Zhang Z; Lan Y; Hu F; Kong F; Qiu Q; Zhang Y
    Blood; 2022 Mar; 139(11):1619-1630. PubMed ID: 35030255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
    Tamai N; Hashii Y; Osuga K; Chihara T; Morii E; Aozasa K; Yoshikawa H
    Skeletal Radiol; 2010 Oct; 39(10):1043-6. PubMed ID: 20309545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha therapy for refractory kaposiform hemangioendothelioma: a single-center experience.
    Wu HW; Wang X; Zhang L; Zhao HG; Wang YA; Su LX; Fan XD; Zheng JW
    Sci Rep; 2016 Oct; 6():36261. PubMed ID: 27796340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.